Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth

Lauren Schwartzberg; Amy Spizuoco

doi:10.12788/cutis.0874

Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth

Lauren Schwartzberg
, Amy Spizuoco

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Alopecia universalis is alopecia areata (AA) with total-body involvement of hair loss. The disease progression is due to autoimmune T cells. We present a case of a patient with alopecia universalis who was successfully treated with tofacitinib.

Original language	English
Pages (from-to)	E5-E9
Journal	Cutis
Volume	112
Issue number	5
DOIs	https://doi.org/10.12788/cutis.0874
State	Published - Nov 2023
Externally published	Yes

Access to Document

10.12788/cutis.0874

Cite this

@article{8133d265aea741c0a4811f731da32935,

title = "Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth",

abstract = "Alopecia universalis is alopecia areata (AA) with total-body involvement of hair loss. The disease progression is due to autoimmune T cells. We present a case of a patient with alopecia universalis who was successfully treated with tofacitinib.",

author = "Lauren Schwartzberg and Amy Spizuoco",

year = "2023",

month = nov,

doi = "10.12788/cutis.0874",

language = "English",

volume = "112",

pages = "E5--E9",

journal = "Cutis",

issn = "0011-4162",

publisher = "Frontline Medical Communications Inc.",

number = "5",

}

TY - JOUR

T1 - Alopecia Universalis Treated With Tofacitinib

T2 - The Role of JAK/STAT Inhibitors in Hair Regrowth

AU - Schwartzberg, Lauren

AU - Spizuoco, Amy

PY - 2023/11

Y1 - 2023/11

N2 - Alopecia universalis is alopecia areata (AA) with total-body involvement of hair loss. The disease progression is due to autoimmune T cells. We present a case of a patient with alopecia universalis who was successfully treated with tofacitinib.

AB - Alopecia universalis is alopecia areata (AA) with total-body involvement of hair loss. The disease progression is due to autoimmune T cells. We present a case of a patient with alopecia universalis who was successfully treated with tofacitinib.

UR - https://www.scopus.com/pages/publications/85179649264

U2 - 10.12788/cutis.0874

DO - 10.12788/cutis.0874

M3 - Article

C2 - 38091428

AN - SCOPUS:85179649264

SN - 0011-4162

VL - 112

SP - E5-E9

JO - Cutis

JF - Cutis

IS - 5

ER -

Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth

Abstract

Access to Document

Fingerprint

Cite this